All chemicals and AR grade solvents were obtained from Sigma-Aldrich (Saint Louis, MO, USA), Merck (Lebanon, NJ, USA) or Alfa Aesar (Tewksbury, MA, USA) and were used as received without further purification. IR spectra were recorded using Bruker MPA FT-IR machine (Karlsruhe, Germany). 1H NMR spectra were recorded at 300 MHz on a Bruker Avance DPX 300 or at 400 MHz Bruker Avance III 400 (BBFO 400) (Karlsruhe, Germany). 13C NMR spectra were recorded at 75.47 MHz on a Bruker Avance DPX 300 or at 101 MHz Bruker Avance III 400 (BBFO 400). Structural assignments were made with additional information from gCOSY, gHSQC, and gHMBC experiments. HRMS were measured using a hybrid Quadrupole Time-of-Flight (Q-TOF) (Waters Xevo G2-X2 MS) on Qstar XL MS/MS system (Milford, CT, USA). LCMS spectra were recorded using Agilent 6530 LCMS (Santa Clara, CA, USA). Single-crystal X-ray crystallographic analysis was done using Bruker D8 Quest (Karlsruhe, Germany). Analytical TLC was performed using Merck 60 F254 precoated silica gel plates (0.2 mm thickness) (Oakville, ON, Canada). The plates were visualized using UV radiation (254 nm) or stained in ceric ammonium sulfate solution with heating to detect the reaction spots. Flash chromatography was performed using Merck silica gel 60 (230–400 mesh) (Oakville, ON, Canada). The general procedure of phenacyl alcohols preparation, synthesis of 3-cyanopyrroles 1a–k, 4a–c, 14a–e, 15a, 16a–b, 17a–b and compounds 22 and 23 are found below.
3.2. General Procedure—Synthesis of 3-Cyanopyrroles 1a–k, 4a–c, 14a–e, 15a, 16a–b, 17a–b
AcOH (1.0 eq.) was added to a stirred solution of the α-hydroxyketones 1, 4, or 14-17 (1.0 eq.), oxoacetonitriles 2, 13, or 18–20 (1.0 eq.), and primary amines 3, 5–12, or 21 (1.1 eq.) in EtOH (3 mL) at room temperature. The reaction mixture was then heated at 70 °C for 3 h. Upon completion (TLC), the reaction mixture was evaporated to dryness under vacuum to produce the crude product as a foam. The foam was purified using silica gel column chromatography using eluent MeOH/CH2Cl2 (5:95 for D-(+)-fructose and 20:80 for isomaltulose) or EtOAc/Hexane (5–35:95–65) as eluants for phenacyl alcohols 14–17 to produce pure 3-cyanopyrroles. All reactions were conducted using 1.0 mmol of the substrates 1, 4, and 14–17. This general procedure was used to prepare 3-cyanopyrroles 1a–k, 4a–c, 14a–e, 15a, 16a–b, and 17a–b.
1-Benzyl-2-Phenyl-5-((1R,2S,3R)-1,2,3,4-Tetrahydroxybutyl)-1H-Pyrrole-3-Arbonitrile (1a)
Obtained by general procedure 2 using D-(+)-fructose 1 (180 mg, 1.0 mmol), benzoylacetonitrile 2 (145 mg, 1.0 mmol), benzylamine 3 (120 µL, 1.1 mmol), and AcOH (57 µL, 1.0 mmol). The reaction produced the desired product 1a (291 mg, 77%) as a hygroscopic pale-yellow solid. IR (KBr film) νmax = 3416, 2221, 1637, 1398, 1077 cm−1. 1H NMR (300 MHz, MeOD) δ 7.43–7.38 (m, 3H), 7.34 (d, J = 5.2 Hz, 2H), 7.29–7.20 (m, 3H), 6.87 (d, J = 7.5 Hz, 2H), 6.79 (s, 1H), 5.40 (d, J = 12.0 Hz, 1H), 5.24 (d, J = 12.0 Hz, 1H), 4.88 (s, 1H), 3.79 – 3.69 (m, 3H), 3.61 (dd, J = 10.0, 4.3 Hz, 1H). 13C NMR (75 MHz, MeOD) δ 143.8, 138.9, 137.6, 131.0, 130.9, 130.4, 129.9, 129.9, 128.5, 126.9, 118.4, 112.0, 92.8, 74.4, 72.9, 66.1, 64.8, 49.4. DEPT135 13C NMR (75 MHz, MeOD) δ 130.9, 130.4, 129.9 (2 × CH signals), 128.5, 126.9, 112.0, 74.4, 72.9, 66.1, 64.8, 49.4. HRMS (ESI-TOF) m/z: [M+H]+ calcd for C22H23N2O4+ 379.1658; found 379.1644.
1-Hexyl-2-Phenyl-5-((1R,2S,3R)-1,2,3,4-Tetrahydroxybutyl)-1H-Pyrrole-3-Carbonitrile (1b)
Obtained by general procedure 2 using D-(+)-fructose 1 (180 mg, 1.0 mmol), benzoylacetonitrile 2 (145 mg, 1.0 mmol), hexylamine 5 (144 µL, 1.1 mmol), and AcOH (57 µL, 1.0 mmol). The reaction produced the desired product 1b (320 mg, 86%) as a hygroscopic pale-yellow solid. IR (KBr film) νmax = 3293, 2957, 2928, 2220, 1447, 1090 cm−1. 1H NMR (300 MHz, MeOD) δ 7.45–7.37 (m, 3H), 7.35–7.29 (m, 2H), 6.56 (s, 1H), 4.95 (s, 1H), 4.06–3.83 (m, 2H), 3.75–3.63 (m, 3H), 3.58–3.49 (m, 1H), 1.48–1.34 (m, 2H), 1.02-0.95 (m, 6H), 0.68 (t, J = 6.9 Hz, 3H). 13C NMR (75 MHz, MeOD) δ 144.5, 138.5, 133.1, 132.5, 131.7, 131.5, 119.9, 113.1, 93.8, 76.2, 74.4, 67.2, 66.3, 47.6, 33.6, 33.4, 28.6, 24.9, 15.7. DEPT135 13C NMR (75 MHz, MeOD) δ 132.5, 131.7, 131.5, 113.1, 76.2, 74.4, 67.2, 66.3, 47.6, 33.6, 33.4, 28.6, 24.9, 15.7. HRMS (ESI-TOF) m/z: [M+Na]+ calcd for C21H28N2O4Na+ 395.1947; found 395.2000.
1-Phenethyl-2-Phenyl-5-((1R,2S,3R)-1,2,3,4-Tetrahydroxybutyl)-1H-Pyrrole-3-Carbonitrile (1c)
Obtained by general procedure 2 using D-(+)-fructose 1 (180 mg, 1.0 mmol), benzoylacetonitrile 2 (145 mg, 1.0 mmol), 2-phenylethylamine 6 (138 µL, 1.1 mmol), and AcOH (57 µL, 1.0 mmol). The reaction produced the desired product 1c (329 mg, 84%) as a hygroscopic pale-yellow solid. IR (KBr film) νmax = 3427, 3341, 2959, 2224, 1434, 1077 cm−1. 1H NMR (300 MHz, MeOD) δ 7.37–7.33 (m, 3H), 7.17–7.1 (m, 2H), 7.05-7.00 (m, 3H), 6.70 (dd, J = 6.6, 2.9 Hz, 2H), 6.58 (s, 1H), 4.99 (d, J = 1.4 Hz, 1H), 4.16–4.07 (m, 2H), 3.77–3.64 (m, 3H), 3.55 (dd, J = 10.2, 4.5 Hz, 1H), 2.69 (t, J = 7.5 Hz, 2H). 13C NMR (75 MHz, MeOD) δ 144.9, 140.5, 138.5, 132.8, 132.4, 131.6, 131.4, 131.3, 131.1, 129.2, 119.9, 113.2, 93.9, 76.3, 74.5, 67.3, 66.3, 49.3, 39.6. DEPT135 13C NMR (75 MHz, MeOD) δ 132.4, 131.6, 131.4, 131.3, 131.1, 129.2, 113.2, 76.3, 74.5, 67.3, 66.3, 49.3, 39.6. HRMS (ESI-TOF) m/z: [M+H]+ calcd for C23H25N2O4+ 393.1814; found 393.1834.
1-(2-(1H-Imidazol-1-yl)ethyl)-2-Phenyl-5-((1R,2S,3R)-1,2,3,4-Tetrahydroxybutyl)-1H-Pyrrole-3-Carbonitrile (1d)
Obtained by general procedure 2 using D-(+)-fructose 1 (180 mg, 1.0 mmol), benzoylacetonitrile 2 (145 mg, 1.0 mmol), 2-(1H-imidazol-1-yl)ethanamine 7 (107 µL, 1.1 mmol), and AcOH (57 µL, 1.0 mmol). The reaction produced the desired product 1d (279 mg, 73%) as a hygroscopic pale-yellow solid. IR (KBr film) νmax = 3407, 2220, 1651, 1400, 1077 cm−1. 1H NMR (300 MHz, MeOD) δ 7.32 (dd, J = 6.2, 2.7 Hz, 3H), 7.05–6.95 (m, 3H), 6.69 (s, 1H), 6.61 (s, 1H), 6.44 (s, 1H), 4.88 (d, J = 2.5 Hz, 1H), 4.48–4.27 (m, 2H), 4.24–4.04 (m, 2H), 3.75–3.62 (m, 3H), 3.55 (dd, J = 10.8, 5.1 Hz, 1H). 13C NMR (75 MHz, MeOD) δ 145.4, 139.6, 138.7, 132.3, 131.8, 131.8, 131.4, 130.7, 122.2, 119.4, 113.8, 94.5, 76.4, 74.6, 67.4, 66.1, 49.3, 48.4. DEPT135 13C NMR (75 MHz, MeOD) δ 139.6, 132.3, 131.8, 131.4, 130.7, 122.2, 113.8, 76.4, 74.6, 67.4, 66.1, 49.3, 48.4. HRMS (ESI-TOF) m/z: [M+H]+ calcd for C22H22BrN2O3+ 441.0814; found 441.0795.
2-Phenyl-1-(Prop-2-yn-1-yl)-5-((1R,2S,3R)-1,2,3,4-Tetrahydroxybutyl)-1H-Pyrrole-3-Carbonitrile (1e)
Obtained by general procedure 2 using D-(+)-fructose 1 (180 mg, 1.0 mmol), benzoylacetonitrile 2 (145 mg, 1.0 mmol), propargylamine 8 (70 µL, 1.1 mmol), and AcOH (57 µL, 1.0 mmol). The reaction produced the desired product 1e (245 mg, 75%) as a hygroscopic pale-yellow solid. IR (KBr film) νmax = 3290, 2219, 1699, 1400, 1089 cm−1. 1H NMR (300 MHz, MeOD) δ 7.49–7.39 (m, 5H), 6.58 (d, J = 0.4 Hz, 1H), 5.17–5.09 (m, 1H), 4.83 (dd, J = 18.2, 2.5 Hz, 1H), 4.60 (dd, J = 18.2, 2.5 Hz, 1H), 3.79–3.65 (m, 3H), 3.57 (dd, J = 10.7, 5.4 Hz, 1H), 2.78 (t, J = 2.5 Hz, 1H). 13C NMR (75 MHz, MeOD) δ 144.6, 138.5, 132.4, 132.0, 131.5, 119.6, 131.5, 94.1, 81.1, 76.9, 75.9, 75.5, 67.6, 66.3, 37.4. DEPT135 13C NMR (75 MHz, MeOD) δ 132.4, 132.0, 131.5, 113.5, 75.9, 74.5, 67.5, 66.3, 37.4. HRMS (ESI-TOF) m/z: [M+H]+ calcd for C22H22BrN2O3+ 441.0814; found 441.0795.
1-(Naphthalen-1-ylmethyl)-2-Phenyl-5-((1R,2S,3R)-1,2,3,4-Tetrahydroxybutyl)-1H-Pyrrole-3-Carbonitrile (1f)
Obtained by general procedure 2 using D-(+)-fructose 1 (180 mg, 1.0 mmol), benzoylacetonitrile 2 (145 mg, 1.0 mmol), 1-naphthylmethylamine 9 (162 µL, 1.1 mmol), and AcOH (57 µL, 1.0 mmol). The reaction produced the desired product 1f (291 mg, 68%) as a hygroscopic pale-yellow solid. IR (KBr film) νmax = 3400, 2922, 2221, 1653, 1479, 1076 cm−1. 1H NMR (400 MHz, MeOD) δ 7.91–7.86 (m, 2H), 7.79 (d, J = 8.3 Hz, 1H), 7.53–7.48 (m, 2H), 7.42 – 7.38 (m, 1H), 7.34 (dd, J = 7.6, 1.8 Hz, 2H), 7.31 – 7.24 (m, 3H), 6.91 (s, 1H), 6.63 (d, J = 7.0 Hz, 1H), 5.79 (dd, J = 84.3, 17.7 Hz, 2H), 4.81 (d, J = 1.9 Hz, 1H), 3.81 (dd, J = 7.8, 2.1 Hz, 1H), 3.72 (dd, J = 10.9, 3.2 Hz, 1H), 3.67–3.62 (m, 1H), 3.58 (dd, J = 10.9, 5.7 Hz, 1H). 13C NMR (101 MHz, MeOD) δ 142.5, 136.4, 133.6, 133.2, 129.7, 129.3, 129.2, 129.0, 128.4 (2 × CH), 127.7, 126.2, 125.8, 125.2, 122.1, 121.9, 117.0, 110.8, 91.5, 73.1, 71.4, 64.7, 63.4, 46.3. DEPT135 13C NMR (101 MHz, MeOD) δ 129.2, 129.0, 128.4 (2 × CH), 127.7, 126.2, 125.8, 125.2, 122.1, 121.9, 110.8, 73.1, 71.4, 64.7, 63.4, 46.3. HRMS (ESI-TOF) m/z: [M+Na]+ calcd for C26H24N2O4Na+ 451.1634; found 451.1610.
1. -Cyclohexyl-2-Phenyl-5-((1R,2S,3R)-1,2,3,4-Tetrahydroxybutyl)-1H-Pyrrole-3-Carbonitrile (1g)
Obtained by general procedure 2 using D-(+)-fructose 1 (180 mg, 1.0 mmol), benzoylacetonitrile 2 (145 mg, 1.0 mmol), cyclohexylamine 10 (127 µL, 1.1 mmol), and AcOH (57 µL, 1.0 mmol). The reaction produced the desired product 1f (266 mg, 72%) as a hygroscopic pale-yellow solid. IR (KBr film) νmax = 3425, 2931, 2224, 1439, 1077 cm−1. 1H NMR (300 MHz, MeOD) δ 7.41–7.39 (m, 3H), 7.32–7.22 (m, 2H), 6.61 (s, 1H), 5.14 (s, 1H), 4.09 (s, 1H), 3.76–3.52 (m, 4H), 1.77 (s, 4H), 1.65 (d, J = 13.0 Hz, 2H), 1.48 (d, J = 12.4 Hz, 1H), 1.20–1.03 (m, 2H), 0.93 (s, 1H). 13C NMR (75 MHz, MeOD) δ 144.5, 138.9, 134.2, 133.2, 131.9, 131.1, 119.8, 113.7, 94.9, 76.5, 74.5, 67.0, 66.4, 61.5, 36.1, 35.9, 28.9 (2 × CH2), 27.8. DEPT135 13C NMR (75 MHz, MeOD) δ 133.2, 131.9, 131.1, 76.5, 74.5, 67.0, 66.4, 61.5, 36.1, 35.9, 28.9 (2xCH2), 27.8. HRMS (ESI-TOF) m/z: [M+H]+ calcd for C21H27N2O4+ 371.1971; found 371.1972.
1,2-Diphenyl-5-((1R,2S,3R)-1,2,3,4-Tetrahydroxybutyl)-1H-Pyrrole-3-Carbonitrile (1h)
Obtained by general procedure 2 using D-(+)-fructose 1 (180 mg, 1.0 mmol), benzoylacetonitrile 2 (145 mg, 1.0 mmol), aniline 11 (100 µL, 1.1 mmol), and AcOH (57 µL, 1.0 mmol). The reaction produced the desired product 1g (222 mg, 61%) as a hygroscopic pale-yellow solid. IR (KBr film) νmax = 3408, 2219, 1635, 1497, 1095 cm−1. 1H NMR (300 MHz, MeOD) δ 7.30–7.25 (br s, 4H), 7.17–7.12 (m, 3H), 7.11–7.07 (m, 2H), 7.02 (s, 1H), 6.77 (d, J = 0.5 Hz, 1H), 4.57 (d, J = 2.0 Hz, 1H), 3.56–3.46 (m, 3H), 3.41 (dt, J = 5.5, 2.4 Hz, 1H). 13C NMR (75 MHz, MeOD) δ 144.4, 140.2, 139.8, 132.4, 132.3, 131.8, 131.7, 131.5, 131.0, 130.8, 119.8, 113.6, 94.6, 76.4, 74.4, 67.3, 66.1. DEPT135 13C NMR (75 MHz, MeOD) δ 132.3, 31.8, 131.5, 131.0, 130.8, 113.6, 76.4, 74.4, 67.3, 66.1. HRMS (ESI-TOF) m/z: [M+H]+ calcd for C21H21N2O4+ 365.1501; found 365.1494.
1-(4-Methoxyphenyl)-2-Phenyl-5-((1R,2S,3R)-1,2,3,4-Tetrahydroxybutyl)-1H-Pyrrole-3-Carbonitrile (1i)
Obtained by general procedure 2 using D-(+)-fructose 1 (180 mg, 1.0 mmol), benzoylacetonitrile 2 (145 mg, 1.0 mmol), p-anisidine 12 (126 µL, 1.1 mmol), and AcOH (57 µL, 1.0 mmol). The reaction produced the desired product 1h (236 mg, 60%) as a hygroscopic pale-yellow solid. IR (KBr film) νmax = 3402, 2942, 2223, 1514, 1400, 1251, 1078 cm−1. 1H NMR (300 MHz, MeOD) δ 7.23–7.08 (m, 6H), 6.98–6.74 (m, 3H), 6.73 (s, 1H), 4.55 (d, J = 1.9 Hz, 1H), 3.68 (s, 3H), 3.59–3.47 (m, 3H), 3.45–3.36 (m, 1H). 13C NMR (75 MHz, MeOD) δ 162.8, 144.6, 140.4, 132.7, 132.6, 132.3, 131.0, 130.8, 119.9, 116.8 (CH), 116.8 (Cq), 113.4, 94.3, 76.5, 74.5, 67.4, 66.1, 57.5. DEPT135 13C NMR (75 MHz, MeOD) δ 132.7, 132.3, 131.0, 130.8, 116.8, 113.4, 76.4, 74.4, 67.3, 66.1, 57.5. HRMS (ESI-TOF) m/z: [M+Na]+ calcd for C22H22N2O5Na+ 417.1426; found 417.1478.
2-Methyl-1-Phenethyl-5-((1R,2S,3R)-1,2,3,4-Tetrahydroxybutyl)-1H-Pyrrole-3-Carbonitrile (1j)
Obtained by general procedure 2 using D-(+)-fructose 1 (180 mg, 1.0 mmol), 3-oxobutanenitrile 13 (83 mg, 1.0 mmol), 2-phenylethylamine 6 (138 µL, 1.1 mmol), and AcOH (57 µL, 1.0 mmol). The reaction produced the desired product 1i (234 mg, 71%) as a hygroscopic pale-yellow solid. IR (KBr film) νmax = 3350, 2944, 2218, 1638, 1429, 1077 cm−1. 1H NMR (400 MHz, MeOD) δ 7.33–7.23 (m, 3H), 7.14 (d, J = 7.6 Hz, 2H), 6.51 (s, 1H), 5.00 (d, J = 1.9 Hz, 1H), 4.32–4.12 (m, 2H), 3.86–3.70 (m, 3H), 3.64 (dd, J = 11.0, 5.1 Hz, 1H), 3.03 (t, J = 7.3 Hz, 2H), 2.04 (s, 3H). 13C NMR (101 MHz, MeOD) δ 138.6, 138.1, 134.3, 128.7, 128.3, 126.5, 117.2, 108.9, 89.2, 73.4, 71.7, 64.2, 63.3, 45.9, 36.6, 9.8. DEPT135 13C NMR (101 MHz, MeOD) δ 128.7, 128.3, 126.5, 108.9, 73.4, 71.7, 64.2, 63.3, 45.9, 36.6, 9.8. HRMS (ESI-TOF) m/z: [M+H]+ calcd for C18H23N2O4+ 331.1658; found 331.1620.
1-Benzyl-2-Methyl-5-((1R,2S,3R)-1,2,3,4-Tetrahydroxybutyl)-1H-Pyrrole-3-Carbonitrile (1k)
Obtained by general procedure 2 using D-(+)-fructose 1 (180 mg, 1.0 mmol), 3-oxobutanenitrile 13 (83 mg, 1.0 mmol), benzylamine 3 (120 µL, 1.1 mmol), and AcOH (57 µL, 1.0 mmol). The reaction produced the desired product 1j (212 mg, 67%) as a hygroscopic pale-yellow solid. IR (KBr film) νmax = 3411, 2217 1636, 1428, 1078 cm−1. 1H NMR (400 MHz, MeOD) δ 7.36–7.24 (m, 3H), 6.98 (d, J = 7.4 Hz, 2H), 6.56 (s, 1H), 5.41 (d, J = 16.0 Hz, 1H), 5.27 (d, J = 16.0 Hz, 1H), 4.88 (s, 1H), 3.76–3.64 (m, 3H), 3.58 (dd, J = 11.0, 5.5 Hz, 1H), 2.25 (s, 3H). 13C NMR (101 MHz, MeOD) δ 138.8, 137.1, 135.0, 128.5, 127.1, 125.5, 117.0, 108.8, 89.9, 73.1, 71.4, 64.5, 63.3, 47.4, 10.0. DEPT135 13C NMR (101 MHz, MeOD) δ 128.5, 127.1, 125.5, 108.8, 73.1, 71.4, 64.5, 63.3, 47.4, 10.0. HRMS (ESI-TOF) m/z: [M+H]+ calcd for C17H21N2O4+ 317.1501; found 317.1503.
1-Hexyl-2-Phenyl-5-((1R,2S,3R)-1,2,3-Trihydroxy-4-(((2S,3R,4S,5S,6R)-3,4,5-Trihydroxy-6-(Hydroxymethyl)tetrahydro-2H-Pyran-2-yl)oxy)butyl)-1H-Pyrrole-3-Carbonitrile (4a)
Obtained by general procedure 2 using isomaltulose 4 (342 mg, 1.0 mmol), benzoylacetonitrile 2 (145 mg, 1.0 mmol), hexylamine 5 (144 µL, 1.1 mmol), and AcOH (57 µL, 1.0 mmol). The reaction produced the desired product 4a (363 mg, 68%) as a hygroscopic pale-yellow solid. IR (KBr film) νmax = 3391, 2928, 2221, 1653, 1457, 1078 cm−1. 1H NMR (300 MHz, MeOD) δ 7.45–7.37 (m, 3H), 7.33 (dd, J = 7.6, 1.8 Hz, 2H), 6.58 (s, 1H), 5.01 (s, 1H), 4.74 (d, J = 3.7 Hz, 1H), 4.04–3.76 (m, 4H), 3.71 (dd, J = 13.4, 3.2 Hz, 2H), 3.61–3.49 (m, 4H), 3.33 (dd, J = 9.6, 3.6 Hz, 1H), 3.27–3.21 (m, 1H), 1.42 (d, J = 5.9 Hz, 2H), 1.1–0.9 (m, 6H), 0.69 (t, J = 6.9 Hz, 3H). 13C NMR (75 MHz, MeOD) δ 144.5, 138.8, 133.1, 132.5, 131.7, 131.5, 120.0, 113.2, 101.7, 93.9, 76.7, 75.4, 75.2, 75.1, 73.2, 72.8, 71.6, 67.0, 64.1, 47.6, 33.6, 33.4, 28.6, 24.9, 15.7. DEPT135 13C NMR (75 MHz, MeOD) δ 132.5, 131.7, 131.5, 113.2, 101.7, 76.7, 75.4, 75.2, 75.1, 73.1, 72.8, 71.6, 67.0, 64.1, 47.6, 33.6, 33.4, 28.6, 24.9, 15.7. HRMS (ESI-TOF) m/z: [M+Na]+ calcd for C27H38N2O9Na+ 557.2475; found 557.2474.
1-Benzyl-2-Phenyl-5-((1R,2S,3R)-1,2,3-Trihydroxy-4-(((2S,3R,4S,5S,6R)-3,4,5-Trihydroxy-6-(Hydroxymethyl)tetrahydro-2H-Pyran-2-yl)oxy)butyl)-1H-Pyrrole-3-Carbonitrile (4b)
Obtained by general procedure 2 using isomaltulose 4 (342 mg, 1.0 mmol), benzoylacetonitrile 2 (145 mg, 1.0 mmol), benzylamine 3 (120 µL, 1.1 mmol), and AcOH (57 µL, 1.0 mmol). The reaction produced the desired product 4b (297 mg, 55%) as a hygroscopic pale-yellow solid. IR (KBr film) νmax = 3402, 2938, 2221, 1636, 1400, 1077, 1028 cm−1. 1H NMR (300 MHz, MeOD) δ 7.30 (dd, J = 6.6, 2.7 Hz, 3H), 7.24–7.20 (m, 2H), 7.13 (dd, J = 10.5, 7.1 Hz, 3H), 6.76 (d, J = 6.7 Hz, 2H), 6.68 (s, 1H), 5.29 (d, J = 16.0 Hz, 1H), 5.11 (d, J = 17.0 Hz, 1H), 4.82 (s, 1H), 4.70 (d, J = 3.6 Hz, 1H), 3.94–3.86 (m, 1H), 3.72–3.68 (m, 3H), 3.60–3.56 (m, 3H), 3.46–3.38 (m, 1H), 3.32 (dd, J = 9.7, 3.7 Hz, 1H), 3.25 (d, J = 9.1 Hz, 1H). 13C NMR (75 MHz, MeOD) δ 145.2, 140.4, 139.3, 132.4, 132.4, 131.8, 131.4 (CH), 131.4 (Cq), 131.3, 130.0, 128.3, 119.9, 113.5, 101.7, 94.2, 76.7, 75.2, 75.1, 73.2, 72.6, 71.4, 67.4, 64.1, 50.9. DEPT135 13C NMR (75 MHz, MeOD) δ 132.4, 131.8, 131.4, 130.0, 128.3, 113.5, 101.7, 76.7, 75.2, 75.0, 73.1, 72.6, 71.4, 67.4, 64.0, 50.9. HRMS (ESI-TOF) m/z: [M+Na]+ calcd for C28H32N2O9Na+ 563.2006; found 563.2002.
1-Hexyl-2-Methyl-5-((1R,2S,3R)-1,2,3-Trihydroxy-4-(((2S,3R,4S,5S,6R)-3,4,5-Trihydroxy-6-(hydroxymethyl)tetrahydro-2H-Pyran-2-yl)oxy)butyl)-1H-Pyrrole-3-Carbonitrile (4c)
Obtained by general procedure 2 using isomaltulose 4 (342 mg, 1.0 mmol), 3-oxobutanenitrile 13 (83 mg, 1.0 mmol), hexylamine 5 (144 µL, 1.1 mmol), and AcOH (57 µL, 1.0 mmol). The reaction produced the desired product 4c (269 mg, 57%) as a hygroscopic pale-yellow solid. IR (KBr film) νmax = 3402, 2931, 2217, 1651, 1429, 1078, 1027 cm−1. 1H NMR (400 MHz, MeOD) δ 6.50 (s, 1H), 5.03 (s, 1H), 4.84 (d, J = 3.7 Hz, 1H), 4.11–3.99 (m, 2H), 3.98–3.89 (m, 1H), 3.87–3.76 (m, 3H), 3.71–3.60 (m, 4H), 3.44 (dd, J = 9.6, 3.7 Hz, 1H), 3.38–3.33 (m, 1H), 2.39 (s, 3H), 1.79–1.67 (m, 2H), 1.38 (s, 6H), 0.94 (t, J = 6.8 Hz, 3H). 13C NMR (101 MHz, MeOD) δ 137.8, 134.4, 117.3, 108.7, 98.8, 89.3, 73.8, 72.5, 72.3, 72.1, 70.3, 69.9, 68.7, 63.9, 61.2, 44.4, 31.2, 30.5, 26.2, 22.3, 13.0, 10.0. DEPT135 13C NMR (101 MHz, MeOD) δ 108.7, 98.8, 73.8, 72.5, 72.3, 72.1, 70.2, 69.8, 68.7, 63.9, 61.2, 44.4, 31.2, 30.5, 26.2, 22.3, 13.0, 10.0. HRMS (ESI-TOF) m/z: [M+Na]+ calcd for C22H36N2O9Na+ 495.2319; found 495.2320.
1-Hexyl-2,5-Diphenyl-1H-Pyrrole-3-Carbonitrile (14a)
Obtained by general procedure 2 using phenacyl alcohol 14 (136 mg, 1.0 mmol), benzoylacetonitrile 2 (145 mg, 1.0 mmol), hexylamine 5 (144 µL, 1.1 mmol), and AcOH (57 µL, 1.0 mmol). The reaction produced the desired product 14a (295 mg, 90%) as a hygroscopic pale-yellow solid. IR (KBr film) νmax = 2956, 2929, 2857, 2220, 1604, 1474, 1346 cm−1. 1H NMR (300 MHz, CDCl3) δ 7.53–7.40 (m, 10H), 6.49 (s, 1H), 4.06–3.94 (m, 2H), 1.25–1.13 (m, 2H), 1.07–0.96 (m, 2H), 0.92–0.79 (m, 4H), 0.71 (t, J = 7.2 Hz, 3H). 13C NMR (75 MHz, MeOD) δ 142.4, 136.2, 132.1, 130.1, 129.7, 129.3, 129.0 (2xCH), 128.8, 128.3, 117.4, 111.8, 92.7, 45.6, 30.7, 30.1, 25.6, 22.1, 13.8. DEPT135 13C NMR (75 MHz, MeOD) δ 129.7, 129.3, 129.0, 129.0, 128.8, 128.3, 111.8, 45.6, 30.7, 301., 25.6, 22.1, 13.8. HRMS (ESI-TOF) m/z: [M+Na]+ calcd for C23H24N2Na+ 351.1837; found 351.1845.
1-Benzyl-2,5-Diphenyl-1H-Pyrrole-3-Carbonitrile (14b)
Obtained by general procedure 2 using phenacyl alcohol 14 (136 mg, 1.0 mmol), benzoylacetonitrile 2 (145 mg, 1.0 mmol), benzylamine 3 (120 µL, 1.1 mmol), and AcOH (57 µL, 1.0 mmol). The reaction produced the desired product 14b (294 mg, 88%) as a hygroscopic pale-yellow solid. IR (KBr film) νmax = 2220, 1473, 1452, 1415, 1346 cm−1. 1H NMR (300 MHz, CDCl3) δ 7.42 (br s, 5H), 7.39–7.30 (m, 5H), 7.21–7.11 (m, 3H), 6.72–6.54 (m, 3H), 5.19 (s, 2H). 13C NMR (75 MHz, MeOD) δ 142.8, 137.4, 136.7, 131.6, 129.7 (CH), 129.7 (Cq), 129.5, 129.2, 128.9, 128.6, 128.5, 128.4, 127.4, 125.9, 117.2, 112.0, 93.3, 49.1. DEPT135 13C NMR (75 MHz, MeOD) δ 129.7, 129.5, 129.2, 128.9, 128.6, 128.5, 128.4, 127.4, 125.9, 112.0, 49.1. HRMS (ESI-TOF) m/z: [M+Na]+ calcd for C24H18N2Na+ 357.1368; found 357.1360.
2-(2-Chlorophenyl)-1-Cyclohexyl-5-Phenyl-1H-Pyrrole-3-Carbonitrile (14c)
Obtained by general procedure 2 using phenacyl alcohol 14 (136 mg, 1.0 mmol), 2-chloro benzoylacetonitrile 18 (152 mg, 1.0 mmol), cyclohexylamine 10 (127 µL, 1.0 mmol), and AcOH (57 µL, 1.0 mmol). The reaction produced the desired product 14c (310 mg, 86%) as a hygroscopic pale-yellow solid. IR (KBr film) νmax = 2943, 2928, 2847, 2220, 1458, 1431, 1338 cm−1. 1H NMR (400 MHz, CDCl3) δ 7.56 (d, J = 8.0 Hz, 1H), 7.49-7.40 (m, 8H), 6.44 (s, 1H), 3.91–3.82 (m, 1H), 1.95 – 1.83 (m, 2H), 1.63 (d, J = 14.0 Hz, 2H), 1.56-1.34 (m, 3H), 1.09 – 0.93 (m, 2H), 0.77-0.71 (m, 1H). 13C NMR (101 MHz, MeOD) δ 138.0, 135.9, 135.8, 133.4, 132.7, 131.1, 130.4, 129.9, 128.5, 128.3, 126.6, 116.5, 111.9, 94.4, 59.6, 33.9, 32.8, 26.2 (2xCH2), 25.0. DEPT135 13C NMR (101 MHz, MeOD) δ 133.4, 131.1, 130.5, 129.9, 128.5, 128.3, 126.6, 111.8, 59.6, 33.9, 32.8, 26.2, 26.2, 25.0. HRMS (ESI-TOF) m/z: [M+Na]+ calcd for C23H21N2ClNa+ 383.1291; found 383.1295.
1,2,5-Triphenyl-1H-Pyrrole-3-Carbonitrile (14d)
Obtained by general procedure 2 using phenacyl alcohol 14 (136 mg, 1.0 mmol), benzoylacetonitrile 2 (145 mg, 1.0 mmol), aniline 11 (100 µL, 1.1 mmol), and AcOH (57 µL, 1.0 mmol). The reaction produced the desired product 14d (256 mg, 80%) as a hygroscopic pale-yellow solid. IR (KBr film) νmax = 2229, 1597, 1493, 1085 cm−1. 1H NMR (300 MHz, CDCl3) δ 7.21–7.18 (m, 5H), 7.17–7.10 (m, 6H), 7.00–6.94 (m, 2H), 6.92–6.86 (m, 2H), 6.64 (s, 1H). 13C NMR (75 MHz, MeOD) δ 141.9, 137.3, 136.1, 131.2, 129.7, 129.4, 129.1, 129.0, 128.6, 128.4, 128.3 (2xCH), 128.2, 127.6, 117.2, 112.0, 93.6. DEPT135 13C NMR (75 MHz, MeOD) δ 129.7, 129.1, 129.0, 128.6, 128.4, 128.3 (2 × CH), 128.2, 127.6, 112.4. HRMS (ESI-TOF) m/z: [M+H]+ calcd for C23H17N2+ 321.1392; found 321.1379.
1-(4-Fluorophenyl)-2,5-Diphenyl-1H-Pyrrole-3-Carbonitrile (14e)
Obtained by general procedure 2 using phenacyl alcohol 14 (136 mg, 1.0 mmol), benzoylacetonitrile 2 (145 mg, 1.0 mmol), 4-fluoroaniline 21 (104 µL, 1.1 mmol), and AcOH (57 µL, 1.0 mmol). The reaction produced the desired product 14e (260 mg, 77%) as a hygroscopic pale-yellow solid. IR (KBr film) νmax = 2227, 1602, 1514, 1489, 1232 cm−1. 1H NMR (300 MHz, CDCl3) δ 7.23–7.09 (m, 8H), 6.97 (dd, J = 6.6, 2.9 Hz, 2H), 6.95-6.80 (m, 4H), 6.63 (d, J = 0.6 Hz, 1H). 13C NMR (75 MHz, MeOD) δ 162.0 (d, J = 247.5 Hz, C-F), 141.9, 136.2, 133.3, 131.0, 130.3, 130.2, 129.8, 129.2, 129.0, 128.6, 128.5, 128.3, 127.7, 117.0, 116.2 (d, J = 22.5 Hz, C-H), 112.1, 93.7. DEPT135 13C NMR (75 MHz, MeOD) δ 130.3, 130.2, 129.8, 129.0, 128.6, 128.5, 128.3, 127.8, 116.3, 116.0, 112.1. HRMS (ESI-TOF) m/z: [M+H]+ calcd for C23H16N2F+ 339.1298; found 339.1283.
1-Benzyl-2-Methyl-5-(p-tolyl)-1H-Pyrrole-3-Carbonitrile (15a)
Obtained by general procedure 2 using 2-hydroxy-1-(p-tolyl)ethan-1-one 15 (150 mg, 1.0 mmol), 3-oxobutanenitrile 13 (83 mg, 1.0 mmol), benzylamine 3 (120 µL, 1.1 mmol), and AcOH (57 µL, 1.0 mmol). The reaction produced the desired product 15a (212 mg, 74%) as a hygroscopic pale-yellow solid. IR (KBr film) νmax = 2218, 1700, 1559, 1496, 1353, 1155 cm−1. 1H NMR (400 MHz, CDCl3) δ 7.35–7.28 (m, 3H), 7.15 (s, 4H), 6.90 (d, J = 7.1 Hz, 2H), 6.42 (s, 1H), 5.11 (s, 2H), 2.36 (s, 3H), 2.30 (s, 3H). 13C NMR (101 MHz, MeOD) δ 138.7, 138.1, 136.9, 135.6, 129.3, 129.1, 129.0, 128.6, 127.6, 125.5, 117.3, 109.8, 92.0, 48.2, 21.2, 11.8. DEPT135 13C NMR (101 MHz, MeOD) δ 129.3, 129.1, 129.0, 127.6, 125.5, 48.2, 21.2, 11.8. HRMS (ESI-TOF) m/z: [M+H]+ calcd for C20H19N2+ 287.1548; found 287.1542.
2-(4-Bromophenyl)-5-(4-Fluorophenyl)-1-Phenethyl-1H-Pyrrole-3-Carbonitrile (16a)
Obtained by general procedure 2 using 1-(4-fluorophenyl)-2-hydroxyethan-1-one 16 (154 mg, 1.0 mmol), 4-bromo benzoylacetonitrile 19 (224 mg, 1.0 mmol), 2-phenylethylamine 6 (138 µL, 1.1 mmol), and AcOH (57 µL, 1.0 mmol). The reaction produced the desired product 16a (365 mg, 82%) as a hygroscopic pale-yellow solid. IR (KBr film) νmax = 2220, 1557, 1493, 1225, 1157, 1071 cm−1. 1H NMR (400 MHz, CDCl3) δ 7.65–7.55 (m, 2H), 7.34–7.28 (m, 2H), 7.22–7.11 (m, 7H), 6.67–6.51 (m, 2H), 6.46 (s, 1H), 4.21 (t, J = 7.0 Hz, 2H), 2.44 (t, J = 7.0 Hz, 2H). 13C NMR (101 MHz, MeOD) δ 162.8 (d, J = 242.4 Hz, C-F), 141.2, 136.7, 135.4, 132.2, 131.2, 131.1 (2xCH), 128.6, 128.4, 127.8 (2xCq), 126.9, 123.6, 116.8, 116.0, 115.8, 112.2, 93.2, 47.1, 36.4. DEPT135 13C NMR (101 MHz, MeOD) δ 132.2, 131.2, 131.1, 131.1, 128.6, 128.4, 126.9, 115.9 (d, J = 20.2 Hz, C-H), 47.1, 36.4. HRMS (ESI-TOF) m/z: [M+H]+ calcd for C25H19N2FBr+ 445.0716; found 445.0730.
5-(4-Fluorophenyl)-2-Methyl-1-Phenyl-1H-Pyrrole-3-Carbonitrile (16b)
Obtained by general procedure 2 using 1-(4-fluorophenyl)-2-hydroxyethan-1-one 16 (154 mg, 1.0 mmol), 3-oxobutanenitrile 13 (83 mg, 1.0 mmol), aniline 11 (100 µL, 1.1 mmol), and AcOH (57 µL, 1.0 mmol). The reaction produced the desired product 16b (193 mg, 70%) as a hygroscopic pale-yellow solid. IR (KBr film) νmax = 2221, 1700, 1559, 1496, 1225, 1160 cm−1. 1H NMR (400 MHz, CDCl3) δ 7.47–7.42 (m, 3H), 7.16–7.11 (m, 2H), 7.04–6.98 (m, 2H), 6.88 (t, J = 8.7 Hz, 2H), 6.52 (s, 1H), 2.29 (s, 3H). 13C NMR (101 MHz, MeOD) δ 162.0 (d, J = 252.5 Hz, C-F), 139.9, 137.4, 134.2, 130.1, 130.0, 129.5, 128.8, 128.1, 127.6, 117.0, 115.3 (d, J = 20.2 Hz, C-H), 110.1, 92.5, 12.4. DEPT135 13C NMR (101 MHz, MeOD) δ 130.1, 130.0, 129.5, 128.8, 128.1, 115.4, 115.2, 110.0, 12.4. HRMS (ESI-TOF) m/z: [M+H]+ calcd for C18H14N2F+ 277.1141; found 277.1138.
1.-Benzyl-5-(4-Chlorophenyl)-2-(3-Methoxyphenyl)-1H-Pyrrole-3-Carbonitrile (17a)
Obtained by general procedure 2 using 1-(4-chlorophenyl)-2-hydroxyethan-1-one 17 (170 mg, 1.0 mmol), 3-methoxy benzoylacetonitrile 20 (175 mg, 1.0 mmol), benzylamine 3 (120 µL, 1.1 mmol), and AcOH (57 µL, 1.0 mmol). The reaction produced the desired product 17a (334 mg, 84%) as a hygroscopic pale-yellow solid. IR (KBr film) νmax = 2221, 1603, 1557, 1487, 1287, 1093 cm−1. 1H NMR (400 MHz, CDCl3) δ 7.38–7.30 (m, 3H), 7.24–7.20 (m, 5H), 7.03 (d, J = 7.9 Hz, 1H), 6.96 (dd, J = 8.3, 2.5 Hz, 1H), 6.91 (d, J = 1.4 Hz, 1H), 6.76–6.66 (m, 2H), 6.60 (s, 1H), 5.17 (s, 2H), 3.69 (s, 3H). 13C NMR (101 MHz, MeOD) δ 159.7, 142.9, 137.5, 135.3, 134.5, 130.6, 130.5, 130.0, 128.8, 128.7, 127.6, 125.8, 122.1, 116.9, 115.6, 114.6, 112.4, 93.5, 55.2, 49.2. DEPT135 13C NMR (101 MHz, MeOD) δ 130.6, 130.0, 128.9, 128.7, 127.6, 125.8, 122.1, 115.6, 114.6, 112.4, 55.2, 49.2. HRMS (ESI-TOF) m/z: [M+H]+ calcd for C25H20N2OCl+ 399.1264; found 399.1274.
5-(4-Chlorophenyl)-2-Methyl-1-Phenyl-1H-Pyrrole-3-Carbonitrile (17b)
Obtained by general procedure 2 using 1-(4-chlorophenyl)-2-hydroxyethan-1-one 17 (170 mg, 1.0 mmol), 3-oxobutanenitrile 13 (83 mg, 1.0 mmol), aniline 11 (100 µL, 1.1 mmol), and AcOH (57 µL, 1.0 mmol). The reaction produced the desired product 17b (205 mg, 70%) as a hygroscopic pale-yellow solid. IR (KBr film) νmax = 2223, 1700, 1559, 1496, 1399, 1094 cm−1. 1H NMR (400 MHz, CDCl3) δ 7.48–7.42 (m, 3H), 7.19–7.11 (m, 4H), 6.96 (d, J = 8.5 Hz, 2H), 6.56 (s, 1H), 2.29 (s, 3H). 13C NMR (101 MHz, MeOD) δ 140.2, 137.3, 133.9, 133.2, 129.9, 129.6, 129.4, 128.9, 128.5, 128.1, 116.9, 110.4, 92.7, 12.4. DEPT135 13C NMR (101 MHz, MeOD) δ 129.6, 129.4, 128.9, 128.5, 128.1, 110.4, 12.4. HRMS (ESI-TOF) m/z: [M+H]+ calcd for C18H14N2Cl+ 293.0846; found 293.0843.
5-Formyl-1-Phenethyl-2-Phenyl-1H-Pyrrole-3-Carbonitrile (22)
NaIO4 (235 mg, 1.1 mmol) was slowly added to a solution of 1c (392 mg, 1.0 mmol) in MeOH (10 mL) at room temperature, and the reaction mixture was stirred at room temperature for 3 h. The reaction mixture was then concentrated under vacuum, diluted with H2O (5 mL), and extracted with ethyl acetate (3 × 30 mL). The combined organic extracts were dried over magnesium sulfate and filtered, and the solvent was then evaporated under vacuum to produce 22 (295 mg, 98%) as a pale-yellow solid. IR (KBr film) νmax = 2228, 1674, 1457, 1404, 1363, 1142 cm−1. 1H NMR (400 MHz, CDCl3) δ 9.67 (s, 1H), 7.50-7.46 (m, 3H), 7.33 (s, 1H), 7.22–7.15 (m, 5H), 6.87 (d, J = 6.5 Hz, 2H), 4.55 (t, J = 7.2 Hz, 2H), 2.90 (t, J = 7.1 Hz, 2H). 13C NMR (101 MHz, MeOD) δ 179.4, 148.5, 137.0, 131.7, 130.2, 129.5, 129.0, 128.7, 128.7, 127.3, 127.3, 126.9, 115.2, 95.0, 48.3, 37.3. DEPT135 13C NMR (101 MHz, MeOD) δ 179.4, 130.2, 129.5, 129.0, 128.7, 128.7, 127.3, 126.9, 48.3, 37.3. HRMS (ESI-TOF) m/z: [M+H]+ calcd for C20H17N2O+ 301.1341; found 301.1335.
5-(Hydroxymethyl)-1-Phenethyl-2-Phenyl-1H-Pyrrole-3-Carbonitrile (23)
NaBH4 (28 mg, 0.74 mmol) was added to a stirred solution of 22 (200 mg, 0.67 mmol) in MeOH (10 mL) at room temperature. Stirring was continued for 1 h (TLC), and the solvent was then evaporated under reduced vacuum. The residue was flushed via silica gel column chromatography and was eluted with a gradient of 40% EtOAc/ hexane to produce 23 (191 mg, 95% yield) as a pale-yellow solid. IR (KBr film) νmax = 3478, 2221, 1674, 1481, 1346 cm−1. 1H NMR (400 MHz, CDCl3) δ 7.51-7.37 (m, 3H), 7.41–7.35 (m, 2H), 7.22-7.19 (m, 3H), 6.84 (s, 2H), 6.45 (s, 1H), 4.51 (s, 2H), 4.27 (t, J = 7.4 Hz, 2H), 2.78 (t, J = 7.3 Hz, 2H). 13C NMR (101 MHz, MeOD) δ 142.7, 137.4, 133.3, 129.6, 129.6, 129.3, 129.0, 128.7, 128.6, 126.9, 117.0, 111.9, 92.1, 56.6, 46.6, 37.2. DEPT135 13C NMR (101 MHz, MeOD) δ 129.6, 129.3, 129.0, 128.7, 128.6, 126.9, 111.9, 56.6, 46.6, 37.2. HRMS (ESI-TOF) m/z: [M+H]+ calcd for C20H19N2O+ 303.1497; found 303.1494.